Dr. Mario Cote, MD is a Internist in Peru, IL with over 18 years of experience. What is your opinion of Dr. Mario Cote, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mario Cote, MD has received over $94,648 which includes payments from the following companies:
$82,256.77 from Novo Nordisk Inc
$9,843.04 from Boehringer Ingelheim Pharmaceuticals, Inc.
$1,297.24 from FOREST PHARMACEUTICALS, INC.
$230.59 from Janssen Pharmaceuticals, Inc
$207.80 from AstraZeneca Pharmaceuticals LP
$114.37 from sanofi-aventis U.S. LLC
$69.71 from Sunovion Pharmaceuticals Inc.
$69.67 from Pfizer Inc.
$62.08 from E.R. Squibb & Sons, L.L.C.
$59.80 from Daiichi Sankyo Inc.
$54.26 from Novartis Pharmaceuticals Corporation
$52.61 from Allergan Inc.
$45.23 from Amarin Pharma Inc.
$44.80 from AbbVie, Inc.
$37.78 from Amgen Inc.
$34.66 from LILLY USA, LLC
$34.04 from GlaxoSmithKline, LLC.
$25.38 from Astellas Pharma US Inc
$18.15 from Janssen Biotech, Inc.
$15.74 from Sanofi Pasteur Inc.
Payments received by Dr. Mario Cote, MD were from the following categories:
$76,193.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!